CES1P2

Across TCGA pan-cancer cohorts, CES1P2 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated CES1P2 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher CES1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CES1P2 expression acts as an unfavorable survival marker, although some lineages such as PAAD and DLBC show a favorable association.

UCS, UVM, and BLCA are the cancer types where CES1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Median	IV	0.304	0.897	.001	90	view →
UVM	OS	Tertile	All	0.337	0.816	<.001	57	view →
BLCA	DFS	Tertile	II,III,IV	0.526	0.651	.011	42	view →
LGG	OS	Tertile	All	0.667	0.846	<.001	39	view →
KIRC	DFS	Tertile	All	0.713	0.821	.018	26	view →
LUAD	OS	Tertile	II,III,IV	0.453	0.628	.028	18	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	18	view →
PRAD	DFS	Tertile	All	0.841	0.944	.001	18	view →
KIRP	DFS	Tertile	All	0.387	0.659	.006	15	view →
PAAD	OS	Tertile	II,III,IV	0.674	0.406	.025	15	view →
BRCA	OS	Tertile	II,III,IV	0.872	0.918	.015	12	view →
HNSC	DFS	Quartile	IV	0.204	0.547	.001	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

CES1P2–UCS (DFS)

Open the UCS breakdown →